MedTrace Logo

Thrombus Analysis of Ischemic Stroke

NCT07043413 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-06-29

No results posted yet for this study

Summary

Patients with acute ischemic stroke who have undergone endovascular thrombectomy will be eligible to be included, and thrombus will be collected after obtaining informed consent. Enrolled patients will receive a comprehensive diagnostic evaluation and the best medical treatment according to recent stroke management guidelines. The mechanism of the stroke will be classified into atherosclerotic, cardiac embolism, others and unknown causes based on diagnostic workup. Patients will be monitored in an outpatient clinic for vascular events including stroke recurrence, death, and bleeding events, which will continue for up to two years after the initial stroke event. Thrombus information related to RNA expression patterns and histological characteristics will be analyzed to classify the stroke mechanism and predict future vascular events after the initial stroke.

Conditions

  • Cerebral Infarction

Interventions

DIAGNOSTIC_TEST

thrombus analysis

Detailed expression pattern of RNA and histological characteristics will be investigated.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-25
Primary Completion
2028-12-31
Completion
2029-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07043413 on ClinicalTrials.gov